The global burden of lung cancer: current status and future trends
- PMID: 37479810
- DOI: 10.1038/s41571-023-00798-3
The global burden of lung cancer: current status and future trends
Abstract
Lung cancer is the leading cause of cancer-related death worldwide. However, lung cancer incidence and mortality rates differ substantially across the world, reflecting varying patterns of tobacco smoking, exposure to environmental risk factors and genetics. Tobacco smoking is the leading risk factor for lung cancer. Lung cancer incidence largely reflects trends in smoking patterns, which generally vary by sex and economic development. For this reason, tobacco control campaigns are a central part of global strategies designed to reduce lung cancer mortality. Environmental and occupational lung cancer risk factors, such as unprocessed biomass fuels, asbestos, arsenic and radon, can also contribute to lung cancer incidence in certain parts of the world. Over the past decade, large-cohort clinical studies have established that low-dose CT screening reduces lung cancer mortality, largely owing to increased diagnosis and treatment at earlier disease stages. These data have led to recommendations that individuals with a high risk of lung cancer undergo screening in several economically developed countries and increased implementation of screening worldwide. In this Review, we provide an overview of the global epidemiology of lung cancer. Lung cancer risk factors and global risk reduction efforts are also discussed. Finally, we summarize lung cancer screening policies and their implementation worldwide.
© 2023. Springer Nature Limited.
Similar articles
-
Epidemiology of lung cancer and lung cancer screening programs in China and the United States.Cancer Lett. 2020 Jan 1;468:82-87. doi: 10.1016/j.canlet.2019.10.009. Epub 2019 Oct 7. Cancer Lett. 2020. PMID: 31600530
-
Global Epidemiology of Lung Cancer.Ann Glob Health. 2019 Jan 22;85(1):8. doi: 10.5334/aogh.2419. Ann Glob Health. 2019. PMID: 30741509 Free PMC article. Review.
-
Global Cancer in Women: Burden and Trends.Cancer Epidemiol Biomarkers Prev. 2017 Apr;26(4):444-457. doi: 10.1158/1055-9965.EPI-16-0858. Epub 2017 Feb 21. Cancer Epidemiol Biomarkers Prev. 2017. PMID: 28223433 Review.
-
One-off low-dose CT for lung cancer screening in China: a multicentre, population-based, prospective cohort study.Lancet Respir Med. 2022 Apr;10(4):378-391. doi: 10.1016/S2213-2600(21)00560-9. Epub 2022 Mar 8. Lancet Respir Med. 2022. PMID: 35276087
-
Global cancer statistics, 2012.CA Cancer J Clin. 2015 Mar;65(2):87-108. doi: 10.3322/caac.21262. Epub 2015 Feb 4. CA Cancer J Clin. 2015. PMID: 25651787
Cited by
-
Nanoscale Extracellular Vesicle-Enabled Liquid Biopsy: Advances and Challenges for Lung Cancer Detection.Micromachines (Basel). 2024 Sep 24;15(10):1181. doi: 10.3390/mi15101181. Micromachines (Basel). 2024. PMID: 39459055 Free PMC article. Review.
-
Discrimination of Lung Cancer and Benign Lung Diseases Using BALF Exosome DNA Methylation Profile.Cancers (Basel). 2024 Aug 5;16(15):2765. doi: 10.3390/cancers16152765. Cancers (Basel). 2024. PMID: 39123492 Free PMC article.
-
Potential Application of the Myocardial Scintigraphy Agent [123I]BMIPP in Colon Cancer Cell Imaging.Int J Mol Sci. 2024 Jul 15;25(14):7747. doi: 10.3390/ijms25147747. Int J Mol Sci. 2024. PMID: 39062992 Free PMC article.
-
Radiogenomics: bridging the gap between imaging and genomics for precision oncology.MedComm (2020). 2024 Sep 9;5(9):e722. doi: 10.1002/mco2.722. eCollection 2024 Sep. MedComm (2020). 2024. PMID: 39252824 Free PMC article. Review.
-
Elevated RACGAP1 Expression Enhances Malignant Potential in Lung Adenocarcinoma and Serves as a Prognostic Factor.J Cancer. 2024 Jun 3;15(13):4244-4258. doi: 10.7150/jca.96334. eCollection 2024. J Cancer. 2024. PMID: 38947404 Free PMC article.
References
-
- Travis, W. D., Brambilla, E., Burke, A. P., Marx, A. & Nicholson, A. G. WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart (IARC, 2015).
-
- Schabath, M. B. & Cote, M. L. Cancer progress and priorities: lung cancer. Cancer Epidemiol. Biomark. Prev. 28, 1563–1579 (2019). - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous